Are Newer Potassium Binding Agents Truly Better? Rethinking Sodium Polystyrene Sulfate and Emerging Therapies for Hyperkalemia
Overview
Overview
Journal
J Gen Intern Med
Publisher
Springer
Specialty
General Medicine
Date
2024 Oct 7
PMID
39375313
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Watson M, Baker T, Nguyen A, Sebastianelli M, Stewart H, Oliver D
. Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study. Am J Kidney Dis. 2012; 60(3):409-16.
DOI: 10.1053/j.ajkd.2012.04.023.
View
2.
Holleck J, Han L, Skanderson M, Bastian L, Gunderson C, Brandt C
. Risk of Serious Adverse Gastrointestinal Events with Potassium Binders in Hospitalized Patients: A National Study. J Gen Intern Med. 2024; 40(3):518-524.
PMC: 11861845.
DOI: 10.1007/s11606-024-08979-1.
View
3.
Holleck J, Roberts A, Marhoffer E, Grimshaw A, Gunderson C
. Risk of Intestinal Necrosis With Sodium Polystyrene Sulfonate: A Systematic Review and Meta-analysis. J Hosp Med. 2021; 16(8):489-494.
DOI: 10.12788/jhm.3655.
View
4.
Hollander-Rodriguez J, Calvert Jr J
. Hyperkalemia. Am Fam Physician. 2006; 73(2):283-90.
View
5.
Noel J, Bota S, Petrcich W, Garg A, Carrero J, Harel Z
. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. JAMA Intern Med. 2019; 179(8):1025-1033.
PMC: 6563537.
DOI: 10.1001/jamainternmed.2019.0631.
View